Latest news
Myeloma Paper of the Day, August 8th, Suggested by Robert Orlowski - OncodailyOncodaily · Sat, 08 Aug 2026 18:16:33 GMTWhat Makes an Optimal CAR T-Cell Therapy Candidate in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 22:04:53 GMTDr Cohen on Future Research Avenues for Cevostamab in R/R Myeloma - OncLiveOncLive · Fri, 07 Aug 2026 19:12:33 GMTAl-Ola Abdallah Reviews Long-Term Teclistamab Outcomes in Multiple Myeloma - OncodailyOncodaily · Fri, 07 Aug 2026 18:39:22 GMTWhy CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 15:09:51 GMTRethinking Myeloma Lenalidomide Maintenance - Oncology Nursing NewsOncology Nursing News · Fri, 07 Aug 2026 13:10:33 GMTWhy Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma - CancerNetworkCancerNetwork · Thu, 06 Aug 2026 22:09:47 GMTAdverse Event Management for Bispecific Antibodies and CAR T-Cell Therapies in Relapsed/Refractory Multiple Myeloma - Pharmacy TimesPharmacy Times · Thu, 06 Aug 2026 12:42:09 GMT